A limitation of our study is an inability to correlate the risk of pancreatic cancer with long-term levels of these plasma markers, since IGF-I, IGF-II, and IGFBP-3 were measured at a single point in time. This evidence concerns the gene IGF1 and familial pancreatic carcinoma.